Qin He
- Molecular Biology
- Cancer Research top 10%
- Biomaterials top 10%
- Biomedical Engineering
- Pharmaceutical Science top 5%
- Topics
- RNA Interference and Gene Delivery (9 papers)Nanoparticle-Based Drug Delivery (7 papers)Nanoplatforms for cancer theranostics (4 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Qin He
21 papers receiving 727 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 425
- Cancer Research 219
- Biomaterials 168
- Biomedical Engineering 110
- Pharmaceutical Science 73
Countries citing papers authored by Qin He
This map shows the geographic impact of Qin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin He more than expected).
Fields of papers citing papers by Qin He
This network shows the impact of papers produced by Qin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin He. The network helps show where Qin He may publish in the future.
Co-authorship network of co-authors of Qin He
This figure shows the co-authorship network connecting the top 25 collaborators of Qin He. A scholar is included among the top collaborators of Qin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin He. Qin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 25 | |
| 3 | 22 | |
| 4 | 4 | |
| 5 | 15 | |
| 6 | 10 | |
| 7 | 31 | |
| 8 | 262 | |
| 9 | 16 | |
| 10 | 35 | |
| 11 | 47 | |
| 12 | 13 | |
| 13 | [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay]. | 3 |
| 14 | 55 | |
| 15 | 2 | |
| 16 | 14 | |
| 17 | 45 | |
| 18 | 89 | |
| 19 | LHRHa aided liposomes targeting to human ovarian tumor cells: preparation and cellular uptake. | 1 |
| 20 | 21 |
About Qin He
Qin He is a scholar working on Biomaterials, Pharmaceutical Science and Immunology, having authored 21 papers that have together received 734 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Cancer Research (219 citations), Biomaterials (168 citations) and Pharmaceutical Science (73 citations). Qin He has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Desheng Xiao, Pan Zou, Yongguang Tao, Hongyu Liu, Cheng Lei, Zhirong Zhang, Qianyu Zhang, Kairong Shi, Jianshu Li and Tao Gong. Their work appears in journals such as Advanced Materials, Biomaterials and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.